Nonalcoholic fatty liver disease test: an external validation cohort

Area of Science:

• Hepatology
• Diagnostic Medicine
• Biomarker Development

Background:

• Non-invasive diagnosis of nonalcoholic fatty liver disease (NAFLD) and its advanced phenotypes like nonalcoholic steatohepatitis (NASH) is a critical unmet need.
• Current non-invasive indices require further validation for accurate clinical application.

Purpose of the Study:

• To validate a novel non-invasive index, the "NAFLD test," for diagnosing NAFLD compared to non-NAFLD controls.
• To assess the NAFLD test's ability to differentiate between simple nonalcoholic fatty liver (NAFL) and NASH.

Main Methods:

• A post-hoc analysis of a previous study was conducted.
• The NAFLD test was calculated in patients with NAFLD and controls, and compared with existing indices like FLI, HSI, ION, and CHAI.
• Performance was evaluated using receiver operating characteristic (ROC) curve analysis.

Main Results:

• The NAFLD test was significantly higher in NAFLD patients versus controls (p < 0.001).
• The NAFLD test was also significantly higher in NASH patients compared to NAFL patients (p = 0.007).
• The area under the ROC curve (AUC) for the NAFLD test was 0.84 for NAFLD vs. non-NAFLD and 0.88 for NASH vs. NAFL, showing comparable or superior performance to existing indices.

Conclusions:

• The NAFLD test is validated as a reliable non-invasive tool for diagnosing NAFLD in an external cohort.
• The NAFLD test demonstrates acceptable accuracy in differentiating between NASH and NAFL.